DAMPening Innate Immunity-Mediated Inflammatory Injury & Fibrosis via the eNAMPT-Neutralizing ALT-100 mAb
Time: 4:45 pm
day: Day Two
Details:
• Explore the MOA behind ALT-100 mAb, a monoclonal antibody targeting eNAMPT, to dampen innate immunity-mediated inflammatory injury and fibrosis
• Delve into the interplay between DAMP signaling and innate immunity, highlighting how the inhibition of eNAMPT holds promise in mitigating inflammatory responses implicated in pulmonary fibrosis progression.